- $6.41bn
- $6.47bn
- $1.51bn
- 57
- 35
- 75
- 56
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Total Revenue | 1,004 | 984 | 1,179 | 1,698 | 1,512 |
Losses, Benefits, and Adjustments | |||||
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 784 | 806 | 864 | 979 | 1,137 |
Operating Profit | 219 | 177 | 315 | 719 | 375 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 233 | 190 | 344 | 721 | 377 |
Provision for Income Taxes | |||||
Net Income After Taxes | 192 | 157 | 279 | 583 | 305 |
Net Income Before Extraordinary Items | |||||
Net Income | 192 | 157 | 279 | 583 | 305 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 192 | 157 | 279 | 583 | 305 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.23 | 3.8 | 6.11 | 12.7 | 6.61 |
Dividends per Share | |||||
Special Dividends per Share |